Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03816709 · ClinicalTrials.gov registry record · NA

Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound

A NA study, sponsored by North Dakota State University.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT03816709 is a NA study that has completed, run by North Dakota State University. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03816709, a NA study, has completed, sponsored by North Dakota State University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be inserted at 1.0, 1.75, and 2.5 cm depths to determine the heating rates. Most modality textbook recommendations for therapeutic ultrasound are based on studies performed with the Omnisound ultrasound machine. Previous research has shown variations in power output across manufacturers, producing differences in tissue temperature increases. No information has been published regarding the heating rates of the Chattanooga Intelect Legend XT machine for ultrasound treatments. By determining the heating rates for this machine, clinicians will be better able to utilize the Chattanooga Intelect Legend XT to help reach therapeutic goals.

Interventions

  • DEVICE Therapeutic Ultrasound

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-02-05
Est. Completion 2020-05-11
Phase NA

Sponsor

North Dakota State University

16 total trials

What the Registry Record Tells You About NCT03816709

The ClinicalTrials.gov registry entry for NCT03816709 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Dakota State University, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Therapeutic Ultrasound is the first listed.

NCT03816709 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03816709 about?

NCT03816709 is a clinical study titled "Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound". The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be...

What is the current status of trial NCT03816709?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-02-05. Estimated completion is 2020-05-11.

What interventions are being tested in trial NCT03816709?

The interventions under investigation include: Therapeutic Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT03816709?

This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.